Invasive zygomycosis in transplant recipients

Area of Science:

• Mycology
• Infectious Diseases
• Transplantation Medicine

Background:

• Zygomycosis is a rare but severe fungal infection primarily affecting immunocompromised individuals.
• Only 160 cases of zygomycosis in transplant recipients have been previously documented.
• Transplant recipients represent a vulnerable population with multiple risk factors for invasive fungal infections.

Observation:

• This study presents four new cases of zygomycosis in organ and bone marrow transplant recipients.
• The cases demonstrate a wide clinical spectrum, including disseminated, rhinocerebral, cutaneous, and pulmonary zygomycosis.
• Observed infections involved critical organs such as the heart and brain, highlighting the potential for rapid dissemination.

Findings:

• Three out of the four reported cases were fatal, underscoring the high mortality associated with zygomycosis in this population.
• The only non-fatal case involved cutaneous zygomycosis, which was successfully treated with surgical resection and antifungal therapy.
• Disseminated and rhinocerebral forms, particularly in bone marrow transplant recipients, exhibited extremely poor prognoses.

Implications:

• A high index of suspicion for zygomycosis is essential in transplant recipients presenting with concerning symptoms.
• Prompt diagnosis and aggressive management, combining surgical intervention with systemic amphotericin-B, are critical for improving patient outcomes.
• Further research into risk stratification and novel therapeutic strategies for zygomycosis in transplant recipients is warranted.